149 related articles for article (PubMed ID: 15882516)
1. [Pathogenesis of primary nonalcoholic fatty liver disease].
Moreno Sánchez D
Med Clin (Barc); 2005 May; 124(17):668-77. PubMed ID: 15882516
[TBL] [Abstract][Full Text] [Related]
2. From fatty liver to fibrosis: a tale of "second hit".
Basaranoglu M; Basaranoglu G; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1158-65. PubMed ID: 23483818
[TBL] [Abstract][Full Text] [Related]
3. Role of mitochondria in non-alcoholic fatty liver disease.
Pessayre D
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S20-7. PubMed ID: 17567459
[TBL] [Abstract][Full Text] [Related]
4. [Etiopathogenesis of non-alcoholic steatohepatitis].
Pérez-Aguilar F
Gastroenterol Hepatol; 2005; 28(7):396-406. PubMed ID: 16137475
[TBL] [Abstract][Full Text] [Related]
5. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
6. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.
Svegliati-Baroni G; Candelaresi C; Saccomanno S; Ferretti G; Bachetti T; Marzioni M; De Minicis S; Nobili L; Salzano R; Omenetti A; Pacetti D; Sigmund S; Benedetti A; Casini A
Am J Pathol; 2006 Sep; 169(3):846-60. PubMed ID: 16936261
[TBL] [Abstract][Full Text] [Related]
7. [Patomechanisms of hepatic steatosis].
Fülöp P; Paragh G
Orv Hetil; 2010 Feb; 151(9):323-9. PubMed ID: 20159747
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
[TBL] [Abstract][Full Text] [Related]
9. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
10. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
Serviddio G; Bellanti F; Vendemiale G
Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
Pettinelli P; Obregón AM; Videla LA
Nutr Hosp; 2011; 26(3):441-50. PubMed ID: 21892559
[TBL] [Abstract][Full Text] [Related]
12. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites.
Neuschwander-Tetri BA
Hepatology; 2010 Aug; 52(2):774-88. PubMed ID: 20683968
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
Begriche K; Massart J; Robin MA; Bonnet F; Fromenty B
Hepatology; 2013 Oct; 58(4):1497-507. PubMed ID: 23299992
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in nonalcoholic fatty liver disease.
Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
16. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis.
Bril F; Lomonaco R; Orsak B; Ortiz-Lopez C; Webb A; Tio F; Hecht J; Cusi K
Hepatology; 2014 Jun; 59(6):2178-87. PubMed ID: 24777953
[TBL] [Abstract][Full Text] [Related]
17. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
18. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.
Purohit V; Russo D; Coates PM
Alcohol; 2004 Aug; 34(1):3-8. PubMed ID: 15670659
[TBL] [Abstract][Full Text] [Related]
19. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.
Rolo AP; Teodoro JS; Palmeira CM
Free Radic Biol Med; 2012 Jan; 52(1):59-69. PubMed ID: 22064361
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigs.
Yang SL; Xia JH; Zhang YY; Fan JG; Wang H; Yuan J; Zhao ZZ; Pan Q; Mu YL; Xin LL; Chen YX; Li K
Sci Rep; 2015 Sep; 5():13980. PubMed ID: 26358367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
